Earlens

Earlens is a privately held medical technology company committed to transforming the hearing experience for millions of people who suffer from hearing loss. The company has developed the Earlens Contact Hearing Solution, which directly activates natural hearing, delivering the broadest bandwidth available today and superior sound quality. This revolutionary, non-surgical hearing solution uses a small lens to vibrate the eardrum, replicating the natural hearing process.

The Earlens Contact Hearing Solution received FDA clearance in 2019 for a second generation of the Earlens technology. Unlike traditional hearing aids, which are in effect tiny speakers that simply turn up the volume on air conducted sound, the Earlens Contact Hearing Solution™ is the world’s first to deliver sound directly to the eardrum.

Earlens headquartered in United States, North America, operates in the Health Care, Medical, Medical Device sector. The company focuses on Health Care and has secured $47.4B in funding across 132 round(s). With a team of 101-250 employees, Earlens is actively contributing to advancements in Health Care. Their latest funding round, Series A - Earlens, raised $4.6M. Discover more about their projects, partnerships, and impact on our platform.